Seattle Genetics rebrands as Seagen as it expands business globally October 9, 2020 Auto Bot BioPharma, biopharma nl, cancer, Oncology, Seagen, Seattle, WASHINGTON 0 The company has received FDA approvals for two cancer drugs in less than 12 months and announced partnerships with Merck last month for a Phase II antibody-drug conjugate and a marketed drug.